Search

(https://blogs.loc.gov/law/2023/03/approaching-peak-bloom-pic-of-the-week/?loclr=bloglaw) Peak bloom came early this year on March 17, 2024 – (https://www.epa.gov/climate-indicators/cherry-blossoms) the earliest in 20 years. This cherry blossom season is bittersweet, as it is the locally beloved [...]

Byline: Bar & Bench A book on Patent Law, written by Delhi High Court judge, Justice Prathiba M Singh and published by Thomson Reuters is set to be launched tomorrow [...]

Canadian drug prices are higher than in many peer countries. What's the remedy? Rather than regulation, we propose relying on the new Canadian Drug Agency to achieve lower prices through [...]

India, June 23 -- Artificial intelligence is overturning the conventional idea of intellectual property rights, especially in drug discovery Artificial intelligence or AI has been shaking up the established system [...]

India, April 22 -- India's ability to eliminate its huge TB burden by 2025 will be a test of both its patent laws and healthcare policy There was a triumphal [...]

India, Sept. 28 -- Cancer, TB patients are urging a reluctant government to use compulsory licences to make life-saving drugs accessible Around the same time as a sluggish government was [...]

Patent law's impact on Right to Repair The international right to repair movement is cutting across industries, from tech, to telecom, and most importantly, the auto industry. The CAR Coalition [...]

ABSTRACT: Pharmaceutical companies often replace prescription drugs that are already on the market with modified versions that have the same active pharmaceutical ingredient. On the surface, such activity seems benign [...]

When I want to introduce my students to the basics of patent law, I start with a very simple patent: the Worm Immobilizer, U.S. Patent 4,800,666. It's a classic garage [...]

PolarityTE announced that the China National Intellectual Property Administration, or CNIPA, issued a Notification of Allowance for Chinese Patent Application No. 201580075326.3. The allowed claims relate to skin-regenerative compositions utilizing [...]

As part of the Biden administration's ongoing campaign to reduce outlays for prescription drugs, FDA is collaborating with the US Patent & Trademark Office (USPTO) to limit patent extensions for [...]

Byline: Our Bureau The US Trade Representative (USTR) has recently released its Special 301 Report, in which the US agency has continued to place India on the 'Priority Watch List' [...]

Applied DNA Sciences has received a Notice of Allowance for its U.S. Patent Application No. 15/466,016 (US 2017/0292206) entitled 'Methods of Marking Cellulosic Products.' According to a media release, the [...]

At first glance, Toyota's patent filing published this month for a vehicle fragrance dispenser comes off as touting a pleasant amenity that'll simply keep a car smelling good. But this [...]

Byline: Philip E. HansenThe start of a new year provides the opportunity for a highly subjective retrospective on 35 years of patent law where we've been and where we might [...]

Digital Ally (DGLY) announced a new development in its ongoing legal battles against Axon (AAXN). The Patent and Trademark Office rejected Axon's most recent challenge to Digital's law enforcement patent [...]

I. Introduction II. Background A. The Foundations of Patent Eligible Subject Matter B. The Supreme Court Builds its Framework for Patent Eligible Subject Matter C. The Supreme Court Creates a [...], Patent eligible subject matter, as stated in 35 U.S.C. 101, includes "any new and useful process, machine, manufacture, or composition of matter." Courts excepted laws of nature, natural phenomena, and abstract ideas from patent eligible subject matter, and recent Supreme court decisions have created uncertainty and controversy as to what is and should be eligible for patenting. This Note discusses proposals to clarify patent eligible subject matter through legislation by three intellectual property advocacy organizations, the Intellectual Property Owners Association (IPO), American Intellectual Property Law Association (AIPLA), and American Bar Association Section of Intellectual Property Law (ABA). This Note compares and contrasts two proposals to amend 35 U.S.C. Section 101, one a joint proposal from the IPO and AIPLA and the other from the ABA. The proposals are substantively similar but take different approaches. The IPO-AIPLA proposal replaces the above three judicial exceptions with two new but similar ones, while the ABA proposal retains the exceptions but restricts only patent claims that would preempt the use of an excepted type of subject matter. This Note recommends that patent owners, inventors, and other interested parties advocate for the ABA proposal because it more closely follows the Supreme Court's stated concern of preemption of the patenting of laws of nature, natural phenomena, and abstract ideas.

Byline: Laxmi Yadav The Federation of Indian Chambers of Commerce and Industry (FICCI) has urged the patent office to amend Form 27 and update Patent Rules in line with international [...]

Byline: Laxmi Yadav Leading pharmaceutical organisations from India and abroad have sought amendment to Section 146 of the Patents Act, 1970 to ensure that patent working disclosures under that section [...]

if you want to address something, as the first step, you have to define the thing. Take patent trolls, for instance. Much maligned, they have never been clearly defined and [...]

The nonwovens industry is embracing the promise of nano-technology and appears to be capitalizing on the potential of nanononwovens, in particular. Nano-filtration, nano-composites and nano-fiber structures with fantastic mechanical properties [...]

Considering that patent law in the United States lies exclusively under the purview of the federal government, and that marijuana has been illegal at the federal level since at least [...]

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.respol.2009.11.006 Byline: Chiara Franzoni (a)(b), Giuseppe Scellato (a)(b) Keywords: Grace period; Patent system; Academic patenting; Knowledge dissemination Abstract: The paper applies a novel methodology to US and EPO patent data to assess how often the 'general grace period' exception is used in the USA and the likely impact of international patent regulations that almost invariably deny such use on the pace of new disclosures in academia. Comparisons of average publication delays of European academic inventors show that the grace period accelerates knowledge communication and that variations are likely to depend on a lack of harmonisation of international legal systems, transaction costs and the presence of a firm among patent assignees. Author Affiliation: (a) Politecnico di Torino, Corso Duca degli Abruzzi 24/b, Torino 10129, Italy (b) BRICK - Collegio Carlo Alberto, Torino, Italy Article History: Received 26 August 2008; Revised 25 November 2009; Accepted 26 November 2009

Combination products have been researched and administered for many years, some successfully and others not. I believe that the combination of several active ingredients into one pill, whilst providing a [...]

The National Institute of Industrial Property (INPI), Argentina rejected Gilead Pharmasset LLC patent application on Sofosbuvir prodrug, an essential medicine to treat hepatitis C. The resolution PN 066898 of INPI [...]

Byline: Derek Hawkins WI Supreme Court Case Name: Impression Products, Inc. v. Lexmark International, Inc. Case No.: 15-1189 Focus: Exhaustion of Patent Rights Lexmark exhausted its patent rights in the [...]

Some companies in the biopharmaceutical industry have considered and discarded their China strategy because they fear that intellectual property in China is unprotectable. This perception was recently bolstered by the [...]

The information gleaned through network ties to industry enables well-connected institutions to develop higher impact patent portfolios. In order to acquire the benefit of such connections the experience in balancing academic and corporate priorities must be maintained to avoid the danger of 'capture' by industrial interest.

(Promulgated by the Ministry of Agriculture on December 30 2002 and effective as of February 1 2003.) Article 1: These Provisions are formulated in accordance with the PRC Protection of [...]

The Patent Cooperation Treaty (PCT) provides an efficient vehicle for obtaining patent protection in some or all of its member countries. US nationals have consistently been the largest national group [...]

IN BRIEF Intellectual Property 101 'Build a better mousetrap and the world will beat a path to your door.' These words are as relevant today as when they were spoken [...]

The technology underlying bitcoin may be in for a patent war FOR fans of bitcoin, a digital currency, the year got off to a volatile start. On January 5th one [...]

India, Nov. 25 -- There are patents and then there are patents, and there is a vast gulf between the two. There are patents that are useful and there are [...]

Jordan Patent priority rights are granted to those from states that are a party to the Paris Convention for the Protection of Industrial Property. A claim for patent priority is [...]

Byline: Amanda Ciccatelli Over the last few years, the United States has been looking for ways to improve its patent system. One example is the recent launch of the Enhanced [...]

Byline: Amanda Ciccatelli Why has there been so much legal talk about the prospects of patent protection for marijuana plants? What states are marijuana manufactures beginning to seek patents for [...]

Byline: Michael Messinger, Deborah Sterling [This article is third in a series] New terrain in patent law brought about by the America Invents Act (AIA) in 2011 is now being [...]

India, April 29 -- There is an uneasy interface between competition policy and patent law, an inherent tension between these regulations. While patent laws give the inventor or the patent [...]

Patent reform is plowing ahead and medtech companies are learning more details about the dramatic changes coming to the patent process. The America Invents Act (AIA) became the first major [...]

Byline: Bart Eppenauer Patent reform issues are back in action again at the U.S. Supreme Court. Last October, the Supreme Court agreed to hear two cases challenging the Federal Circuit's [...]

Byline: Bryant C. Boren Jr., Amy Liang Recent changes in the patent law landscape have left patent holders and patent practitioners uncertain about issues that have a major impact on [...]

Byline: Amanda Ciccatelli The enactment of the America Invents Act (AIA) Treaty in March 2013 aligned the U.S. patent system became with the rest of the world, effectively transitioning it [...]

Byline: Allison Bell State health insurance regulators and exchange managers are starting to think harder about how to change everything, even if the Patient Protection and Affordable Care Act (PPACA) [...]

The U.S. Embassy in Beijing publishes on its Web site the information that, on average, 20 percent of the consumer products in China are counterfeit. The site is an embassy [...]

[ILLUSTRATION OMITTED] Intellectual property laws in the U.S. are rooted in the Constitution. U.S. patent and copyright laws exist to promote and encourage the fruits of creativity without unduly restricting [...]

When former Coalition Provisional Authority (CPA) administrator L. Paul Bremer III left Baghdad after the so-called 'transfer of sovereignty' in June 2004, he left behind the 100 orders he enacted [...]